TAXES ON INCOME (Schedule of Deferred Tax Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
In respect of:
Research and development expenses	$ 9,548	$ 7,217
Other timing differences	(2,115)	(1,989)
Net operating loss carry forwards	56,377	56,292
Valuation allowance	(63,810)	(61,520)
Total net deferred tax assets	$ 0	$ 0